News & Media
Press Center & More

Up-to-date press releases and statements in all categories, as well as materials for journalists.

Go to press releases
Mar 6, 2023

Novavax to Participate in TD Cowen's 43rd Annual Health Care Conference

Full text
Download
Mar 2, 2023
Corporate and finance

Novavax Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4)

Full text
Download
Feb 28, 2023
Corporate and finance

Novavax Reports Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights

Full text
Download
All press releases

Media contact

Email: [email protected]
Phone: (202) 709-5563

A practitioner priming a hypodermic needle
Patient getting shot in arm
Syringe and vial

Images, videos, and files for media use

Extensive materials for members of the press, including broadcast, online, film, radio and print journalists.

Explore & download

About Novavax

Novavax, Inc. (Nasdaq: NVAX) is a biotechnology company that promotes improved health globally through the discovery, development and commercialization of innovative vaccines to prevent serious infectious diseases.

Explore opportunities